Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from CardieX ( (AU:CQT) ).
CONNEQT Health Limited has reported significant sales growth for its CONNEQT Pulse arterial health monitor since its launch in January 2025. The company has achieved over 50% quarter-on-quarter sales growth, with September quarter sales reaching US$325k and an annualized revenue run-rate exceeding US$3.5 million. To meet increasing demand, the company has ordered 10,000 additional units. With strong sales momentum and growing brand awareness, CONNEQT is focused on scaling production and optimizing marketing efficiency, with plans to introduce additional subscription and data-driven features to enhance recurring revenue opportunities.
More about CardieX
CONNEQT Health is a company focused on advancing medical technology in vascular health, offering products that include medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders. Their products are based on the market-leading SphygmoCor® vascular biomarker technology, and the company is listed on the Australian Stock Exchange under the ticker ASX: CQT.
Average Trading Volume: 524,892
Technical Sentiment Signal: Sell
Current Market Cap: A$15.39M
See more data about CQT stock on TipRanks’ Stock Analysis page.